Search
for
Sort by
Research 541–570 of 1000+
- Male hormonal contraception: looking back and moving forward
- Female pattern hair loss
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Venous thromboembolism and women's health
- The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study
- Contraception and the dermatologist
- The Hirsute Woman: Challenges in Evaluation and Management
- The Contribution of Endogenous and Exogenous Factors to Female Alopecia
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Androgenetic alopecia; drug safety and therapeutic strategies
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne
- Female Adolescent Hair Disorders
- <i>In Vitro</i>and<i>in Vivo</i>Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring
- Topical Minoxidil Therapy and Hair Regrowth
- Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life
- Solubilities of Flutamide, Dutasteride, and Finasteride as Antiandrogenic Agents, in Supercritical Carbon Dioxide: Measurement and Correlation
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Systemic causes of hair loss
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia